Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity-Reference-Cited by-同舟云学术

Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity

Published:2021-02 Issue: Volume:211 Page:113065
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Mackwitz Marcel K.W.,Hesping Eva,Eribez Korina,Schöler Andrea,Antonova-Koch Yevgeniya,Held Jana,Winzeler Elizabeth A.,Andrews Katherine T.,Hansen Finn K.

Funder

Deutsche Forschungsgemeinschaft

Griffith University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference57 articles.

1. Artemisinin resistance: current status and scenarios for containment;Dondorp;Nat. Rev. Microbiol.,2010

2. Artemisinin resistance in Plasmodium falciparum malaria;Dondorp;N. Engl. J. Med.,2009

3. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda;Uwimana;Nat. Med.,2020

4. New developments in anti-malarial target candidate and product profiles;Burrows;Malar. J.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity;European Journal of Medicinal Chemistry;2024-11

2. 1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors;Scientific Reports;2023-11-29

3. 1,3-diphenylureido hydroxamate: a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors;2023-08-28

4. Random Forest Model Predictions Afford Dual-Stage Antimalarial Agents;ACS Infectious Diseases;2022-07-27

5. Design and synthesis of novel hydroxamic acid derivatives based on quisinostat as promising antimalarial agents with improved safety;Acta Materia Medica;2022-05-17